Healthgevitys formulation includes an optimal ratio of salcaprozate sodium to our active ingredients
Phase 2 clinical trial data published in the New England Journal of Medicine (Jastreboff et al., 2023) demonstrated mean body weight reductions of up to approximately 24% over 48 weeks in adults with obesity a notable finding, though long-term durability data and head-to-head comparisons with other treatments are not yet available
You acknowledge no refunds or returns will be authorized for any medication purchased through this website
Watch for cloudiness, visible particles or precipitate, a color shift (most peptides are colorless GHK-Cu is the exception and reads blue, which is normal), or foam that will not settle
Description GLOW Peptide Blend BPC-157 | TB-500 | GHK-CU 70mg GLOW Blend is a premium peptide stack that combines BPC-157, TB-500, and GHK-CU into a single 70mg formula